주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 11:46 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
1,792 )
기사목록 보기 형태
제목형
요약형
포토형
LG Chem’s growth hormone Eutropin S Pen Inj. wins approval
Kim Chan-hyuk
2022.04.14 15:32
When will SMA oral drug Evrysdi get insurance benefits?
Kim Yun-mi
2022.04.14 12:14
Shionogi says non-clinical trial results will not affect Covid-19 drug approval
Kim Chan-hyuk
2022.04.14 12:12
China OKs HK inno.N's gastroesophageal reflux therapy
Lee Han-soo
2022.04.14 12:11
RedHill Biopharma’s opaganib effective against Omicron
Kim Yun-mi
2022.04.13 15:38
AZ’s new cancer drug may overcome CTAL-4 inhibitor’s toxicity
Kim Yun-mi
2022.04.13 12:06
SK Bioscience to make nasal-type antiviral medicine through international cooperation
Lee Han-soo
2022.04.13 12:03
Is Kolon TissueGene's Invossa set to make a comeback?
Lee Han-soo
2022.04.13 12:03
LG Chem speeds up premium filler trial in China
Kim Chan-hyuk
2022.04.12 16:56
Lumakras shows benefit in longest data from KRAS-mutated NSCLC patients
Kim Yun-mi
2022.04.12 16:53
'Tabrecta will triple overall survival of NSCLC patients’
Lee Han-soo
2022.04.12 16:46
FDA OKs Yuyu’s P2 study for dry eye treatment
Lee Han-soo
2022.04.12 12:01
처음
이전
이전
이전
141
142
143
144
145
146
147
148
149
150
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기